We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
San Diego-based Ligand Pharmaceuticals said it has received $2 million in milestone payments as part
of research collaboration with Merck that is due to expire next month. Xconomy
